When evaluating B12 Injections vs Oral Supplements, the better option depends on the individuals medical history, severity of deficiency, and absorption capacity
Although 5-amino-1MQ has not yet been extensively studied in this context, its demonstrated ability to increase NAD+ levels in other tissues has prompted interest in exploring whether similar effects may occur in the brain
Consult a licensed healthcare provider before using any peptide
Dosing typically begins at a lower dose, suggested initiation of 4 units (0.04 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 1-4: Inject 4 units (0.04 mL) one time per week Weeks 5-8: Inject 8 units (0.08 mL) one time per week Weeks 9-12: Inject 18 units (0.18 mL) one time per week Weeks 13-16: Inject 30 units (0.3 mL) one time per week Week 16+: Inject 44 units (0.44 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
Answering this question is the key to your long-term health
Molecular Identity of AOD9604 AOD9604 is commonly described as a synthetic 16-amino-acid peptide comprising an N-terminal tyrosine linked to the human growth hormone 177191 region